secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aquestive Therapeutics, Inc. (AQST)
CIK:        0001398733
Form:       8-K
Filed at:   2025-09-08T23:59:59+00:00
Accession:  0001398733-25-000018
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aquestive presents at H.C. Wainwright conference; no material updates disclosed
-------------------------------------------------------------------------------

- Investor presentation furnished as Exhibit 99.1; only cover slide text included in filing.
- No financial results, pipeline data, or guidance changes provided in the 8-K.
- Filing is a routine Regulation FD disclosure for a conference presentation.
- No specific numbers, names, or events beyond the presentation's existence.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1398733/000139873325000018/0001398733-25-000018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1398733/000139873325000018/aqst-20250908.htm
  HTML page:      https://secwatch.observer/filing/0001398733-25-000018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer